News Merck, Pfizer covering bases with SGLT2 inhibitor latecomer This year's American Diabetes Association conference takes place right next to San Diego's baseball stadium - and like the city's well-known Padres team, Merck and Pfizer are hoping to
News Sanofi/Regeneron PCSK9 lowers cholesterol in diabetes patien... Companies awaiting CV outcomes trial, and court decision in patent case
News Senate could back Trump health law by 4th July, despite warn... Reforms could take away health insurance from 23 million, and deny insurance to those with pre-existing conditions, such as diabetes
News ADA to re-evaluate tweet ban after backlash ADA says photo ban is to protect intellectual property.
Views & Analysis ADA preview: cardio data in diabetes, drug costs and healthc... Invokana data could suggest cardio benefit for SGLT2 class.
Oncology LSX2026: Addressing adult eye cancer, with Roi Raz Roi Raz, CEO of ReBio Pharma, discusses injectable, bioresorbable sustained release delivery for ophthalmic therapeutics at LSX 2026.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.